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intRoduCtion Cervical cancers rarely metastasize to the ovaries. The proportion of cases presenting with ovarian metastases at the time of surgery ranges from 0.6 to 1.5%. 1 In terms of histological type, adenocarcinomas are more likely to metastasize to the ovaries than squamous cell carcinomas (SCCs). In different case series, 5-8% of cervical adenocarcinomas vs 0.4-1.3% of SCCs metastasized to ovary. [1] [2] [3] We present a rare case of cervical SCC with bilateral ovarian metastasis in a 44-year-old female. The fact that the histological type is SCC and affects both ovaries makes this case even more unique.
Case RepoRt
CW is a 44-year-old female with four living children, who presented with an 8-month history of abnormal vaginal bleeding that started as intramenstrual spotting progressed to copious post-coital bleeding at presentation. She had occasional abdominal cramps and early satiety and no history of weight changes or constipation. No other systemic manifestations were elicited; she had a PAP smear test 6 years earlier that was normal. On clinical exam, the only positives were palpable abdominopelvic mass measuring 8 cm and a cervical tumour 3 cm with no evidence of parametrial, pelvic side wall or rectal involvement.
An ultrasound revealed a complex cystic mass with vascular mural nodules and ascites seen within the right adnexa ( Figure 1 ).
A bulky uterine cervix with a thickened endometrium that was heterogeneous in appearance was also noted. A staging MRI pelvis was also done ( Figure 2) . A heterogeneous mass was seen arising from the cervix with endoluminal extension into the endometrial cavity. The mass was causing obliteration of the anterior fornix of the vagina with evidence of parametrial invasion anteriorly and on the left. The lower third of the vagina was normal and there was no evidence of bladder or rectal invasion. Also seen were complex masses with cystic and solid components arising from both ovaries. Moderate amount of ascites, peritoneal deposits and para-aortic lymphadenopathy were also seen. The rest of the solid and hollow abdominopelvic viscera including the visualized bone marrow signals were unremarkable. Provisional diagnosis at this stage was cervical malignancy with evidence of parametrial invasion (FIGO Stage IIb) and bilateral complex adnexal masses with ascites and peritoneal deposits suggestive of primary ovarian malignancy.
Biopsy of the cervix was SCC of the cervix and an ultrasound-guided biopsy of the ovarian mass was a SCC. The patient was stages as metastatic cervical cancer. Following tumour board discussion, the patient was started to systemic therapy with carboplatin and paclitaxel to reduce the disease burden. disCussion Cervical cancer is one of the rare cause of metastasis to the ovary with a literature review of published studies 
BJR|case reports
Kuria et al indicating that the incidence of ovarian metastasis from uterine cervical cancer ranges between 0.6 and 1.5%. 1 Varying proportions are noted when the histopathology type is considered. Adenocarcinomas are more likely to metastasize to the ovaries than SCCs. In different case series, 5-8% of cervical adenocarcinomas vs 0.4-1.3% of SCCs metastasized to ovary. [1] [2] [3] Our patient had histology of SCC.
Most of the reported metastases to the ovary are usually microscopic, unilateral, confined to ovarian parenchyma and detected post-operatively. 4, 5 The mean age of presentation with ovarian metastases is 57.4 years for SCC and 50.2 years for adenocarcinoma, 6 mostly presenting with signs and symptoms related to the cervical lesion (vaginal bleeding, pelvic pain or abnormal cytology). 2 Our patient presented earlier at 45 years with an 8-month history of irregular per vaginal bleeding. 
